Publicaciones en colaboración con investigadores/as de Université Catholique de Louvain (12)

2022

  1. IMI2-PainCare-BioPain-RCT1: study protocol for a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by peripheral nerve excitability testing (NET)

    Trials, Vol. 23, Núm. 1

  2. IMI2-PainCare-BioPain-RCT2 protocol: a randomized, double-blind, placebo-controlled, crossover, multicenter trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by non-invasive neurophysiological measurements of human spinal cord and brainstem activity

    Trials, Vol. 23, Núm. 1

  3. Pharmacological Probes to Validate Biomarkers for Analgesic Drug Development

    International Journal of Molecular Sciences, Vol. 23, Núm. 15

2021

  1. IMI2-PainCare-BioPain-RCT3: a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by electroencephalography (EEG)

    Trials, Vol. 22, Núm. 1

2016

  1. Cyclosporine A-loaded lipid nanoparticles in inflammatory bowel disease

    International Journal of Pharmaceutics, Vol. 503, Núm. 1-2, pp. 196-198

  2. Reformulating cyclosporine A (CsA): More than just a life cycle management strategy

    Journal of Controlled Release, Vol. 225, pp. 269-282

2014

  1. Vascular endothelial growth factor-loaded injectable hydrogel enhances plasticity in the injured spinal cord

    Journal of Biomedical Materials Research - Part A, Vol. 102, Núm. 7, pp. 2345-2355

2013

  1. Injectable alginate hydrogel loaded with GDNF promotes functional recovery in a hemisection model of spinal cord injury

    International Journal of Pharmaceutics, Vol. 455, Núm. 1-2, pp. 148-158

2012

  1. Brain drug delivery systems for neurodegenerative disorders

    Current Pharmaceutical Biotechnology, Vol. 13, Núm. 12, pp. 2388-2402

  2. Cellular pharmacokinetics and intracellular activity against Listeria monocytogenes and Staphylococcus aureus of chemically modified and nanoencapsulated gentamicin

    Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 9, pp. 2158-2164

2011

  1. In vitro and in vivo efficacy of edelfosine-loaded lipid nanoparticles against glioma

    Journal of Controlled Release, Vol. 156, Núm. 3, pp. 421-426

2010

  1. Incorporating physiological and biochemical mechanisms into pharmacokinetic-pharmacodynamic models: A conceptual framework

    Basic and Clinical Pharmacology and Toxicology